E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/26/2007 in the Prospect News High Yield Daily.

Advanced Medical Optics sets price talk for $200 million notes at 7½% to 7¾%

By Michelle Anderson

Rochester, N.H., March 26 - Advanced Medical Optics, Inc. set price talk for its $200 million offering of 10-year senior subordinated notes (B2/B) at 7½% to 7¾%, according to a market source.

The books will close Tuesday morning ET on the Rule 144A/Regulation S with registration rights deal.

UBS Investment Bank is the left bookrunner. Goldman Sachs & Co. is the joint bookrunner. Banc of America Securities LLC is co-manager.

The notes come with five years of call protection.

Proceeds will be used to partially fund the acquisition of Intralase Corp.

Advanced Medical Optics is a Santa Ana, Calif.-based ophthalmic medical devices company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.